Abstract:BC‐specific sEV network was characterized by enriched cell adhesion and immunomodulatory molecules, in which the contribution of CAFs was highlighted. BC tissue‐derived sEVs presented a stronger immunostimulatory function than in vitro models. Moreover, some noncancer cell‐derived sEV biomarkers in circulation have great diagnostic potential. Small extracellular vesicles (sEVs) are essential mediators of intercellular communication within the tumor microenvironment (TME). Although the biological features of sEVs have been characterized based on in vitro culture models, recent evidence indicates significant differences between sEVs derived from tissue and those derived from in vitro models in terms of both content and biological function. However, comprehensive comparisons and functional analyses are still limited. Here, we collected sEVs from breast cancer tissues (T‐sEVs), paired normal tissues (N‐sEVs), corresponding plasma (B‐sEVs), and tumor organoids (O‐sEVs) to characterize their transcriptomic and proteomic profiles. We identified the actual cancer‐specific sEV signatures characterized by enriched cell adhesion and immunomodulatory molecules. Furthermore, we revealed the significant contribution of cancer‐associated fibroblasts in the sEV network within the TME. In vitro model‐derived sEVs did not entirely inherit the extracellular matrix‐ and immunity regulation‐related features of T‐sEVs. Also, we demonstrated the greater immunostimulatory ability of T‐sEVs on macrophages and CD8+ T cells compared to O‐sEVs. Moreover, certain sEV biomarkers derived from noncancer cells in the circulation exhibited promising diagnostic potential. This study provides valuable insights into the functional characteristics of tumor tissue‐derived sEVs, highlighting their potential as diagnostic markers and therapeutic agents for breast cancer.

The signature of extracellular vesicles in hypoxic breast cancer and their therapeutic engineering

Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities

Extracellular vesicles in the treatment and diagnosis of breast cancer: a status update

Engineered Extracellular Vesicles for Cancer Therapy

Exosomes: Small Vesicles with Important Roles in the Development, Metastasis and Treatment of Breast Cancer

Proteomic Profiling of Serum Extracellular Vesicles Identifies Diagnostic Signatures and Therapeutic Targets in Breast Cancer

Biological Roles and Clinical Applications of Exosomes in Breast Cancer: A Brief Review

Extracellular vesicles remodel tumor environment for cancer immunotherapy

Extracellular vesicles released by hypoxia-induced tumor-associated fibroblasts impart chemoresistance to breast cancer cells via long noncoding RNA H19 delivery

Tumor-derived extracellular vesicles in breast cancer: From bench to bedside

Hypoxia-Induced Adaptations of N-Glycomes and Proteomes in Breast Cancer Cells and Their Secreted Extracellular Vesicles

Extracellular vesicles in the tumor microenvironment: old stories, but new tales

Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management

Therapeutic Prospects of Extracellular Vesicles in Cancer Treatment

The interplay between the tumor microenvironment and tumor-derived small extracellular vesicles in cancer development and therapeutic response

Extracellular vesicles in the HCC microenvironment: Implications for therapy and biomarkers

Tumoral hypoxic extracellular vesicles create a protective microenvironment for triple-negative breast cancer

Extracellular Vesicles in Cancer Immune Microenvironment and Cancer Immunotherapy

Integrated transcriptomics, proteomics, and functional analysis to characterize the tissue‐specific small extracellular vesicle network of breast cancer

Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance